- Patients Patients
Reproductive Genetics Testing
Patient Resources
Cost & Billing
- Providers Providers
- Genetic Counseling
- Login Login
- Estimate My Cost
Your partner for preconception, pregnancy and pediatric care worldwide
Explore Labcorp's cutting-edge noninvasive prenatal genetic screening options, including MaterniT® for cell-free DNA screening, Inheritest® for comprehensive carrier screening, and donor infectious disease testing. Benefit from our extensive clinical expertise and services designed to enhance patient experiences at every stage of life.
Since the acquisition of Sequenom in 2016, Labcorp offers the first globally commercialized prenatal cfDNA screening test, MaterniT 21 PLUS, and the first genome-wide prenatal cfDNA screening test, MaterniT GENOME. We also offer GENOME-Flex, which provides an alternative pathway when late-stage anomalies are suspected. GENOME-Flex allows us to rapidly re-sequence previously run MaterniT 21 PLUS samples using the deeper sequencing power of MaterniT GENOME, giving you options if a second prenatal cfDNA screen is required.
Every pregnancy is unique. MaterniT delivers results whether you are managing routine or high-risk pregnancies which may include:
After performing more than 3 million prenatal cfDNA screening tests, we know that not all positive results are created equal. The Mosaicism Ratio result, only available with MaterniT 21 PLUS (at no extra cost), can refine your patient's risk for aneuploidy by helping to differentiate between a positive result that is more likely to be a true positive, and one with an increased chance to be a false positive.1
We support our global partners and patients in over 50+ countries worldwide and aim to be your dedicated partner
for leading-edge medical laboratory tests and services.
Watch
Watch
Mirar
References